[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioMarin's stock is near its 1-year low, but social sentiment remains overwhelmingly positive, with investors discussing the Inozyme acquisition and its potential impact.
BioMarin Pharmaceutical, Inc. is a biotechnology company specializing in therapies for rare genetic diseases.
BioMarin Pharmaceutical, Inc. uses the ticker $BMRN for trading. Listed in the Stocks and category within the Healthcare sectors.
Price 24-Hour Chart Data
The stock price is under pressure near its 1-year low due to a mix of investor concerns about the Inozyme acquisition, despite positive sentiment and analyst opinions. The price has decreased in the last year but has had a small positive bump in the last day and week.
24-Hour | 7-Day | 30-Day |
---|---|---|
-XXXX% | XXX% | XXXX% |
1-Year High: $XXXXX on 2024-08-20
1-Year Low: $XXXXX on 2025-06-23
AltRank 24-Hour Chart Data
BioMarin Pharmaceutical, Inc. (BMRN) is currently AltRank #1,536 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +685
1 Month: XXXXX +599
6 Months: XXXXX +1,198
1 Year: XXXXX +1,130
1-Year High: XXXXX on 2025-04-05
1-Year Low: X on 2025-02-16
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XX -X
1 Month: XX +5
6 Months: XX +19
1 Year: XX -X
1-Year High: XX on 2024-08-20
1-Year Low: XX on 2025-06-18
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXX +94%
1 Month: XXXXXXX +17%
6 Months: XXXXXXXXX +210%
1 Year: XXXXXXXXX +66%
1-Year High: XXXXXXX on 2025-02-19
1-Year Low: XXX on 2025-03-30
Social Network | X | YouTube | News | |
---|---|---|---|---|
Engagements | XXXXXX | XXXXX | X | XX |
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX +43%
1 Month: XXXXX +88%
6 Months: XXXXX +4.70%
1 Year: XXXXX +64%
1-Year High: XXX on 2025-06-30
1-Year Low: XX on 2024-07-31
Social Network | X | YouTube | News | |
---|---|---|---|---|
Mentions | XXX | XX | X | XX |
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning BioMarin Pharmaceutical, Inc. (BMRN) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XX
1 Week: XXX +23%
1 Month: XXX +215%
6 Months: XXXXX +47%
1 Year: XXXXX +98%
1-Year High: XXX on 2025-06-30
1-Year Low: XX on 2025-01-27
The most influential creators that mention BioMarin Pharmaceutical, Inc. in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@bhukyamanguraju1 | X | XX | X | XXXXX |
@Quantumup1 | X | XXXXX | X | XXXXX |
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% +37%
1 Year: XX% -X%
1-Year High: XXX% on 2024-07-30
1-Year Low: XX% on 2025-03-21
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXX | X% | XXXXX | X% | XXXXX | XX% |
YouTube | XXXXX | XX% | XXXXX | XX% | X | X% |
News | X | X% | X | X% | X | X% |
XX | X% | XX | X% | X | X% | |
Total | XXXXX | XX% | XXXXX | XX% | XXXXX | XX% |
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.011%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-06-30
1-Year Low: XXXXXX% on 2025-07-12
Market Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-02
1-Year Low: XXXXX% on 2025-07-25
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX +$3.30%
1 Month: $XXXXXXXXXXXXXX +$9%
6 Months: $XXXXXXXXXXXXXX -$11%
1 Year: $XXXXXXXXXXXXXX -$30%
1-Year High: $XXXXXXXXXXXXXX on 2024-08-20
1-Year Low: $XXXXXXXXXXXXXX on 2025-06-23
Top assets mentioned In the posts about BioMarin Pharmaceutical, Inc. in the last XX hours
Bitcoin Incognito (XBI) Sarepta Therapeutics, Inc. (SRPT) Bit Digital, Inc. (BTBT) SuperRare (RARE) Vertex Protocol (VRTX) Alnylam Pharmaceuticals, Inc. (ALNY) Regeneron Pharmaceuticals Inc (REGN) GameCredits (GAME) SBET (SBET)
Top topics mentioned In the posts about BioMarin Pharmaceutical, Inc. in the last XX hours
stocks healthcare, stocks, $inzy, nvda, vrtx, exas, $asnd, $xbi, $srpt, investment, $btbt, $ibb, #ytshorts, amgn, jpm, arx, $rare, spx, primary market, ytshorts, mstr, manat, teva, money, stockmarket, anita, qqq, pltr, hims, $vrtx, spce, mrna, sny, pfe, bmnr, acquisition, lun, ter, qubt, $rckt, $alny, nasdaq, telo, united states dollar, $regn, cnc, atm, $game, $sbet, spy, $alxn, morgan stanley, thc, $nvs, $eth, bold, $nbix, debt, $btc, hood, gme, bmrn biomarin, bbai, $sdlb, $mreo, $ctos, $lixt, $jdzg, welcome to, eternal, mira, coins energy, $mstr, multi, fl, $tbla, aal, vir, apt, sonn, $tsla, market cap, ethereum, coins layer 1, trader, $adpt, novo, twitter, elon musk, shak, asml, Sentiment, glxy, nrix, playing, #viral, sharplink, stocks crypto treasuries, asts, tem
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Not sure what to make of this one but will be an interesting one to observe $BMRN"
@fundmyfund on X 2025-07-25 17:55:21 UTC 6126 followers, XXX engagements
"powerful words of god shiva#shiva#god#mahadev#devotional#shorts#love#mantra#shivagod#song#mahadeva"
@bhukyamanguraju1 on YouTube 2025-07-25 16:52:46 UTC XXX followers, 2305 engagements
"@GuyAdami Starting DCA $FCX & $GOOGL Any thoughts on $BMRN"
@StepsReal on X 2025-07-25 15:45:44 UTC 2474 followers, XX engagements
"Citi reiterated - Plus Opened a 30-Day Upside Catalyst Watch on $PTCT (Neutral-$50). $BMRN $OTSKY Citi in its note said "We are not expecting challenges to sepiapterin's approvability for PKU and in fact think the rise in $PTCT stock since 1Q earnings (+30% since May 6th) has increasingly been reflective of pricing in a sepiapterin approval. Data from its phase X APHENITY study demonstrated increased efficacy or better safety / tolerability over the two currently approved therapeutics for PKU and we do see a segment of patients for whom sepiapterin could be an option - particularly for"
@Quantumup1 on X 2025-07-25 13:08:21 UTC 3530 followers, 1058 engagements